Subtotal $0.00
Shop Now
Ozempic not working usually means one of a few things: it is still early, the expectation does not match what the medicine is approved for, weight loss has leveled off, or something else is pushing the other way. Ozempic is approved to lower blood sugar and reduce heart and kidney risks in adults with type 2 diabetes, not for weight loss, and weight loss in its diabetes trials was modest. Even on Wegovy, the weight-management version of semaglutide, about one in six adults in the main trial did not reach 5% weight loss after 68 weeks. Response varies widely, and people with type 2 diabetes tend to lose less. The safest next step is a review with your prescriber; changing how you use the medicine on your own is not.
Peptide Labs does not sell Ozempic, Wegovy, Mounjaro, Zepbound or any prescription drug. This article summarizes FDA labels and published trial results. For what typical results look like over time, see our overview of results in GLP-1 trials.
Key Takeaways
- Ozempic is approved for type 2 diabetes; its main measure of success is blood sugar, not weight.
- In the main Wegovy trial, 83.5% reached at least 5% weight loss at 68 weeks versus 31.1% on placebo.
- In adults with type 2 diabetes, 67.4% reached 5% on Wegovy, so lower responses are common in diabetes.
- Labels start at a low strength and increase gradually, so early weeks are not a fair test.
- Other medicines, hormone conditions, short sleep and eating patterns can all slow weight loss.
- Compounded and counterfeit products are not FDA-reviewed for quality; ask where yours came from.
Is Ozempic not working, or is it too early?
The labels for Ozempic, Wegovy and Zepbound all start people on a low strength and increase it gradually over several weeks, mainly to limit stomach side effects. Semaglutide has a half-life of about a week and reaches steady levels after four to five weeks at a given strength, so the first month or two says little about the long-term response. Our guide to how quickly these medicines act walks through the label timelines and what trials measured at each stage.
The Wegovy label does not name a specific week for judging whether the medicine is working. In the trials, the main results were measured after 68 weeks for Wegovy and 72 weeks for Zepbound, and weight kept falling for many months before leveling off.
Is there such a thing as an Ozempic non responder?
There is no official definition of an Ozempic non responder. Trials commonly use 5% of starting weight as the threshold for a meaningful response, and the Wegovy and Zepbound labels report how many people reached it. The table shows those figures; everyone in these trials also received advice on diet and physical activity.
| Trial in the U.S. label | Who took part | Reached at least 5% weight loss | Label revision |
|---|---|---|---|
| Wegovy, 68 weeks (STEP 1) | 1,961 adults with obesity or overweight, no diabetes | 83.5% on Wegovy vs 31.1% on placebo | June 2026 |
| Wegovy, 68 weeks (STEP 2) | 807 adults with type 2 diabetes | 67.4% vs 30.2% | June 2026 |
| Wegovy with intensive lifestyle therapy, 68 weeks (STEP 3) | 611 adults without diabetes | 84.8% vs 47.8% | June 2026 |
| Zepbound, 72 weeks (SURMOUNT-1) | Adults with obesity or overweight, no diabetes | 85.1% to 90.9% across strengths vs 34.5% | August 2026 |
| Zepbound, 72 weeks (SURMOUNT-2) | Adults with type 2 diabetes | 79.2% to 82.8% vs 32.5% | August 2026 |
Read the other way, roughly 15% to 33% of people taking these medicines did not reach 5% weight loss, depending on the trial, while about a third of placebo users did. Average losses were also smaller in people with type 2 diabetes: 9.6% on Wegovy versus 14.9% in the trial without diabetes. A smaller response than a friend’s is normal variation, not proof that something is wrong.
Ozempic is a diabetes medicine first
If you take Ozempic for type 2 diabetes, working means lower blood sugar, which your prescriber tracks with tests such as HbA1c. The label lists three approved uses: improving blood sugar control, reducing the risk of major heart events in people with diabetes and heart disease, and reducing the risk of kidney decline and heart-related death in people with diabetes and chronic kidney disease.
Weight loss is a side benefit. In Ozempic’s 30-week monotherapy trial, people lost only about 2.6 to 3.5 kg more than those on placebo. Ozempic can be doing its main job well while the scale barely moves. Wegovy and Zepbound are the versions approved for chronic weight management; how they compare is covered in our article on alternatives to Ozempic.
Why am I not losing weight on Ozempic? Common reasons
If you are asking why am I not losing weight on Ozempic, these are the factors most often involved. Several can apply at once.
- Type 2 diabetes. As the table shows, people with diabetes lose less on average, and better blood sugar control itself can mean the body loses less glucose in urine.
- Other medicines. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) lists medicines that may contribute to weight gain: some used for epilepsy, depression or psychotic disorders, corticosteroids, insulin and sulfonylureas, some blood pressure medicines such as beta-blockers, and some antihistamines. Never stop these without talking to the prescriber.
- Hormone conditions. NIDDK names polycystic ovary syndrome, Cushing’s syndrome and hypothyroidism as conditions linked to weight gain; only a clinician can test for them.
- Sleep and stress. NIDDK links too little sleep and long-term stress with weight gain.
- What and how you eat. Appetite falls, but calorie-dense drinks, grazing and ultra-processed snacks can still add up. Our eating guide for GLP-1 medicines covers protein, fiber and meal patterns.
- Missed weeks or interruptions. Gaps from side effects, travel or supply problems can reset progress; your prescriber or pharmacist will explain the label’s instructions for your product.
People taking metformin alongside a GLP-1 medicine sometimes ask whether it adds weight loss; our article on metformin and weight summarizes the evidence.
Wegovy not working after months? Plateaus are expected
When Wegovy is not working after many months of steady loss, a plateau is the most common explanation. In the trials, weight curves fell steeply for the first year and then flattened, as a smaller body needs less energy and appetite signals adapt. Our article on why weight loss stalls explains the biology and what the evidence supports, such as strength training to protect lean mass and an honest look at intake.
Could the product be the problem?
Approved pens come with a lot number, expiration date and storage instructions, and heat or freezing can damage them, so ask your pharmacist if anything about storage is in doubt. Products from outside the normal pharmacy system are a bigger question. The FDA says it does not review compounded drugs for safety, effectiveness or quality before they are sold, and that some compounded semaglutide uses salt forms, semaglutide sodium or acetate, which are different active ingredients from the approved drugs. As of May 31, 2026, the agency had received 990 adverse-event reports linked to compounded semaglutide and more than 730 linked to compounded tirzepatide. It also warns that counterfeit products may contain too little, too much or none of the active ingredient. Our guide to compounded GLP-1 products has the details.
What to ask your prescriber
Bring a short record of your weight, meals, side effects and any missed weeks, plus a list of every medicine and supplement you take. Useful questions include:
- Is my blood sugar or HbA1c responding, even if my weight is not?
- Am I on the strength the label intends for my situation, or still in the starting phase?
- Could any of my other medicines be working against weight loss?
- Should I be tested for thyroid problems or other conditions?
- Would a dietitian or a structured exercise program help?
- Is a different approved medicine worth discussing if my response stays low?
Do not raise the strength, combine products or switch sources on your own. Changes in strength, timing and medicine choice belong to your prescriber, guided by the label.
Frequently Asked Questions
Why is Ozempic not working for me?
Common reasons are that it is still early, you have type 2 diabetes, weight has plateaued, or other medicines, conditions, sleep or eating patterns are working against it. A prescriber can sort out which applies.
How many people do not respond to semaglutide?
In the main Wegovy trial, 16.5% of adults did not reach 5% weight loss after 68 weeks. In adults with type 2 diabetes, about a third did not.
Why am I not losing weight on Ozempic but my blood sugar is better?
Ozempic is approved for blood sugar control. Weight loss in its diabetes trials was modest, so better glucose with little weight change is a common pattern.
What should I do if Wegovy is not working?
Keep a record of weight, meals, side effects and missed weeks, and review it with your prescriber. Do not change the strength yourself.
Is there a test for being an Ozempic non responder?
No. There is no official test or definition; trials commonly use 5% weight loss as the threshold for a meaningful response.
Can compounded semaglutide be less effective?
The FDA does not review compounded drugs for effectiveness or quality, and some use salt forms that differ from the approved ingredient, so results cannot be assumed to match the trials.
Peptide Labs does not sell GLP-1 medicines or any prescription drug. This article is general information, not medical advice. Read the Medication Guide that comes with a prescription, and ask a pharmacist or prescriber how this information applies to you.
Last reviewed October 2026.
Related guides: How Long Does Ozempic Take to Work? Labels and Trials Explained, Weight Loss Plateau: Why It Happens and What the Evidence Says Helps, GLP-1 for Weight Loss: What the Trials Actually Showed.